Ambu's new duodenoscope reaches over 98 percent success rate
Clinical testing of Ambu's improved duodenoscope, the Ascope Duodeno 1.5, continues to yield promising results, the medtech company reports on Monday.
by marketwire, translated by daniel pedersen
Ambu has once again obtained positive results from clinical testing of its improved single-use duodenoscope, the Ascope Duodeno 1.5, it reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
